サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1679389

セリアック病治療市場規模、シェア、動向分析レポート：治療別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten Degrading Enzymes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
セリアック病治療市場規模、シェア、動向分析レポート：治療別、流通チャネル別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年02月21日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

セリアック病治療市場動向

世界のセリアック病治療市場規模は2024年に6億9,020万米ドルと推定され、2025～2030年にかけてCAGR 11.7%で成長すると予測されています。

その最たるものは、診断されたセリアック病患者の世界の有病率の上昇です。最近の推定によると、アメリカ人の約100人に1人がセリアック病に罹患しているが、かなりの割合が診断されていないです。このような診断例の増加は、認知度の向上と診断能力の向上に起因しており、効果的な治療法や診断手法に対する需要の増加に直結します。セリアック病市場はこのような患者数の増加から恩恵を受け、医薬品の技術革新を促進し、専門的な食事管理の必要性を拡大しています。

セリアック病の症状や早期診断の重要性についての一般的な知識が広まるにつれて、医療機関への受診や検査を積極的に希望する患者が増えており、症例の特定に貢献しています。Beyond Celiacが2023年に行った調査では、アメリカ人の約50%しかセリアック病やグルテン過敏症について知らないことが明らかになりました。しかし、拡大するグルテンフリー食品産業は、セリアック病を管理する人々に多様な食事の選択肢を提供しています。このような製品の利用可能性は、患者が食事制限を遵守する上で重要な役割を果たすため、健康状態が改善し、市場の成長に寄与します。

ポイントオブケア検査（POCT）の進歩などの検出方法の改善により、早期発見と介入が容易になり、より迅速で効果的な治療につながっています。高リスク層を対象としたスクリーニングプログラムなど、多くの国にわたる政府の取り組みが市場開拓をさらに後押ししています。このような積極的な対策は、診断症例数を増やし、患者にタイムリーな診断と治療選択肢へのアクセスを提供することで、より包括的で積極的な医療アプローチを促進します。注目すべきは、セリアック病に対する認識を高め、診断や治療へのアクセスを向上させるためのプログラムが各国で実施されていることで、この拡大しつつある健康問題への取り組みが強調されていることです。

新たな治療法の研究開発は、今後数年間におけるセリアック病治療の新たな発展を保証するものです。抗炎症薬や治療用ワクチンの開発は、治療の選択肢を増やし、市場機会を拡大すると期待されています。さらに、医療支出の増加と、特に新規治療法の研究開発活動の活発化が、市場拡大の原動力となる展望です。主要企業は医薬品やグルテンフリー製品への投資を増やしており、これは患者の健康増進、市場浸透の促進、拡大する消費者層への対応に重点を置いていることを示しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 セリアック病治療市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析
    • パイプライン分析

第4章 セリアック病治療市場：治療ビジネス分析

  • 治療市場シェア、2024年と2030年
  • 治療セグメントダッシュボード
  • 市場規模と予測と動向分析、治療別、2018～2030年
  • ビタミンとミネラル
  • グルテン分解酵素
  • 治療（抗炎症薬、抗ヒスタミン薬、その他）
  • その他

第5章 セリアック病治療市場：流通チャネルビジネス分析

  • 流通チャネル市場シェア、2024年と2030年
  • 流通チャネルセグメントダッシュボード
  • 市場規模と予測と動向分析、流通チャネル別、2018～2030年
  • 病院薬局
  • 小売薬局
  • その他

第6章 セリアック病治療市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Teva Pharmaceutical Industries Ltd.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC.
    • GLENMARK PHARMACEUTICALS LTD.
    • Takeda Pharmaceutical Company Limited
    • Hikma Pharmaceuticals PLC
    • Viatris Inc.
    • Zydus Pharmaceuticals, Inc.
    • Novartis Pharmaceuticals Corporation
    • BioLineRx
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global celiac disease treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 Global celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 North America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 U.S. Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 Canada celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 14 Mexico celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Europe celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 UK Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Germany celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Germany celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 France Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Italy celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Italy celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Spain celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Spain celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Norway celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Denmark celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Denmark celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Sweden celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 33 Sweden celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Japan celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Japan celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 China celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 China celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 India celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 India celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Australia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Australia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 South Korea celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 46 South Korea celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Thailand celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 48 Thailand celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Latin America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Latin America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Brazil celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 53 Brazil celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Argentina celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 55 Argentina celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 South Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 South Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63 UAE celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 64 UAE celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Kuwait celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 66 Kuwait celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Celiac disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment and distribution channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Celiac disease treatment market dynamics
  • Fig. 12 Celiac disease treatment market: Porter's five forces analysis
  • Fig. 13 Celiac disease treatment market: PESTLE analysis
  • Fig. 14 Celiac disease treatment market: Treatment segment dashboard
  • Fig. 15 Celiac disease treatment market: Treatment market share analysis, 2024 & 2030
  • Fig. 16 Vitamins & minerals market, 2018 - 2030 (USD Million)
  • Fig. 17 Gluten degrading enzymes market, 2018 - 2030 (USD Million)
  • Fig. 18 Symptomatic treatment (anti-inflammatory drugs, antihistamines, others) market, 2018 - 2030 (USD Million)
  • Fig. 19 Other treatments market, 2018 - 2030 (USD Million)
  • Fig. 20 Celiac disease treatment market: Distribution channel segment dashboard
  • Fig. 21 Celiac disease treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 22 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 23 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 24 Other distribution channels market, 2018 - 2030 (USD Million)
  • Fig. 25 Celiac disease treatment market revenue, by region
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. country dynamics
  • Fig. 30 U.S. celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada country dynamics
  • Fig. 32 Canada celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico country dynamics
  • Fig. 34 Mexico celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 UK country dynamics
  • Fig. 37 UK celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany country dynamics
  • Fig. 39 Germany celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 France country dynamics
  • Fig. 41 France celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy country dynamics
  • Fig. 43 Italy celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain country dynamics
  • Fig. 45 Spain celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway country dynamics
  • Fig. 47 Norway celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia country dynamics
  • Fig. 60 Australia celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand country dynamics
  • Fig. 64 Thailand celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil country dynamics
  • Fig. 67 Brazil celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 MEA celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait country dynamics
  • Fig. 78 Kuwait celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 79 Company categorization
  • Fig. 80 Company market position analysis
  • Fig. 81 Strategic framework
目次
Product Code: GVR-4-68040-488-7

Celiac Disease Treatment Market Trends:

The global celiac disease treatment market size was estimated at USD 690.2 million in 2024 and is projected to grow at a CAGR of 11.7% from 2025 to 2030. Foremost among these is the escalating prevalence of diagnosed celiac disease cases globally. According to recent estimates, approximately 1 in 100 Americans suffers from celiac disease, although a significant proportion of cases remain undiagnosed. This rise in diagnosed instances, attributed to increased awareness and improved diagnostic capabilities, directly translates into a greater demand for effective treatments and diagnostic methodologies. The market benefits from this increasing patient base, driving pharmaceutical innovation and expanding the need for specialized dietary management.

As public knowledge about celiac disease symptoms and the crucial role of early diagnosis continues to grow, individuals are increasingly proactively seeking medical consultations and testing, thereby contributing to the increased identification of cases. Notably, a 2023 survey by Beyond Celiac revealed that only approximately 50% of Americans know anything about celiac disease or gluten sensitivity, indicating a growing awareness gap that needs to be bridged. However, the expanding gluten-free food industry offers a diverse range of dietary options for individuals managing the disease. The availability of these products plays a significant role in patient adherence to dietary restrictions, thereby improving health outcomes and contributing to market growth.

Improvements in detection methods, such as advancements in point-of-care testing (POCT), have facilitated earlier identification and intervention, leading to quicker and more effective treatment. Government initiatives across numerous nations, including screening programs targeting high-risk demographics, further bolster market development. These proactive measures increase the number of diagnosed cases and provide patients with timely access to diagnostics and treatment options, thereby promoting a more comprehensive and proactive healthcare approach. Notably, various countries have implemented programs to raise awareness about celiac disease and enhance access to diagnostics and treatment, underscoring the commitment to addressing this growing health concern.

Ongoing research into new therapeutic modalities assures novel developments in the treatment of celiac disease in the coming years. The development of anti-inflammatory drugs and therapeutic vaccines is expected to enhance treatment options and expand market opportunities. Furthermore, increasing healthcare expenditure and robust R&D activities, particularly in novel treatment alternatives, are poised to drive market expansion. Key players are increasingly investing in drugs and gluten-free products, indicating an emphasis on improving patient health, driving market penetration, and catering to an expanding consumer base.

Global Celiac Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global celiac disease treatment market report based on treatment, distribution channel, and region:

  • Treatment Outlook (Revenue, USD Million, 2018 - 2030)
  • Vitamins & Minerals
  • Gluten Degrading Enzymes
  • Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
  • Other Treatments
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Celiac Disease Treatment Market: Treatment Business Analysis

  • 4.1. Treatment Market Share, 2024 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Vitamins & Minerals
    • 4.4.1. Vitamins & Minerals Market, 2018 - 2030 (USD Million)
  • 4.5. Gluten Degrading Enzymes
    • 4.5.1. Gluten Degrading Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
    • 4.6.1. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others) Market, 2018 - 2030 (USD Million)
  • 4.7. Other Treatments
    • 4.7.1. Other Treatments Market, 2018 - 2030 (USD Million)

Chapter 5. Celiac Disease Treatment Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.6. Other Distribution Channels
    • 5.6.1. Other Distribution Channels Market, 2018 - 2030 (USD Million)

Chapter 6. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Teva Pharmaceutical Industries Ltd.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Amgen Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Amneal Pharmaceuticals LLC.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. GLENMARK PHARMACEUTICALS LTD.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Takeda Pharmaceutical Company Limited
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Hikma Pharmaceuticals PLC
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Viatris Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Zydus Pharmaceuticals, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Novartis Pharmaceuticals Corporation
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. BioLineRx
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives